Erratum: Voluntary opioid tapering-reply (JAMA Internal Medicine (2018) 178:6 (875) DOI: 10.1001/jamainternmed.2018.2112)
JAMA Internal Medicine, ISSN: 2168-6114, Vol: 182, Issue: 6, Page: 690-null
2022
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Correction Description
Clarification of Conflict of Interest Disclosures: In the Reply Letter “Voluntary Opioid Tapering—Reply,”1 published in June 2018, Dr Darnall’s disclosure statement should have read as follows: “DrDarnall reported serving as a consultant for Axial Health regarding the development of physician education materials on opioid prescribing and safety, receiving shares from the company, and that payments for consulting services were paid to Stanford University; serving on the advisory board for Clinical Pain Advisor, an online pain media outlet, and that compensation for her serviceswas paid to Stanford University; receiving royalties from 2 books on patient self-help for opioid reduction and painmanagement for chronic pain; and receiving from Tarsus and Neurovations travel reimbursements to present pain research findings at the PainWeek conference and the Kauai Pain Conference, respectively.” The article has been corrected online.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85128915570&origin=inward; http://dx.doi.org/10.1001/jamainternmed.2022.0814; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85131702290&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35435926; https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2791390; https://dx.doi.org/10.1001/jamainternmed.2022.0814; https://jamanetwork.com/abusenotice
American Medical Association (AMA)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know